Skip to main content
Top
Published in: International Urogynecology Journal 7/2018

01-07-2018 | Original Article

Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study

Authors: Mehmet Giray Sönmez, Yunus Emre Göğer, Gökhan Ecer, Ahmet Atıcı, Mehmet Serkan Özkent, Ahmet Öztürk

Published in: International Urogynecology Journal | Issue 7/2018

Login to get access

Abstract

Introduction and hypothesis

In this study, we planned to explore the effects of sodium bicarbonate orally (NaHCO3) treatment on female patients with lower urinary tract symptoms (LUTS) who have acidic urine pH values (<6).

Methods

NaHCO3 was given orally to 33 female patients for 4 weeks at a dose of 2 × 4 g/day. Laboratory values, bladder diary, the Patient Perception of Bladder Condition Score (PPBC), Patient Perception of Intensity of Urgency Scale (PPIUS), Overactive Bladder–Validated 8-question Awareness tool (OAB-V8), Pelvic Pain and Urgency & Frequency Patient Symptom Scale tests (PUFSS), and the King’s Health Questionnaire (KHQ) scores before and after treatment were compared.

Results

A significant increase was detected in urine pH values measured after treatment (5.31 ± 0.52 to 7.2 ± 0.66, p < 0.001), but not in blood pH values (7.369 ± 0.33 to 7.384 ± 0.28, p = 0.14). After treatment, a significant decrease was detected in daily frequency, nocturia, urgency, and urge incontinence prevalence (p < 0.001,p = 0.003, p < 0.001, p = 0.002, respectively) and PPBC, PPIUS, PUFSS, and OAB-V8 symptom scores (p = 0.004, p = 0.002, p < 0.001, p < 0.001, respectively). A significant decrease was detected in all KHQ subunit scores.

Conclusion

Urine alkalinization with NaHCO3 orally in female patients with LUTS and acidic urine pH has a significant level of positive effects on symptoms and symptom scores. Our results show that this new treatment modality—which is inexpensive, easy to use, and has a low side-effect profile is effective in this chronic patient group.
Literature
1.
go back to reference Varella LR, Bezerra da Silva R, Eugênia de Oliveira MC, Melo pH, Maranhão TM, Micussi MT. Assessment of lower urinary tract symptoms in different stages of menopause. J Phys Ther Sci. 2016;28(11):3116–21.CrossRefPubMedPubMedCentral Varella LR, Bezerra da Silva R, Eugênia de Oliveira MC, Melo pH, Maranhão TM, Micussi MT. Assessment of lower urinary tract symptoms in different stages of menopause. J Phys Ther Sci. 2016;28(11):3116–21.CrossRefPubMedPubMedCentral
2.
go back to reference Denys MA, Anding R, Tubaro A, Abrams P, Everaert K. Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014. Neurourol Urodyn. 2016;35(2):278–82.CrossRefPubMed Denys MA, Anding R, Tubaro A, Abrams P, Everaert K. Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014. Neurourol Urodyn. 2016;35(2):278–82.CrossRefPubMed
3.
go back to reference Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7.CrossRefPubMed Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7.CrossRefPubMed
4.
go back to reference Bilge C, Beji NK. Life quality scales used for evaluating Urinar symptoms in women. J Female Funct Urol. 2015;1-4:41–5. Bilge C, Beji NK. Life quality scales used for evaluating Urinar symptoms in women. J Female Funct Urol. 2015;1-4:41–5.
5.
go back to reference Sanford MT, Rodriguez LV. The role of environmental stress on lower urinary tract symptoms. Curr Opin Urol. 2017;27(3):268–73.CrossRefPubMed Sanford MT, Rodriguez LV. The role of environmental stress on lower urinary tract symptoms. Curr Opin Urol. 2017;27(3):268–73.CrossRefPubMed
6.
go back to reference Zhang HL, Huang ZG, Qiu Y, Cheng X, Zou XQ, Liu TT. Tamsulosin for treatment of lower urinary tract symptoms in women:a systematic review and meta-analysis. Int J Impot Res. 2017;29(4):148–56.CrossRefPubMed Zhang HL, Huang ZG, Qiu Y, Cheng X, Zou XQ, Liu TT. Tamsulosin for treatment of lower urinary tract symptoms in women:a systematic review and meta-analysis. Int J Impot Res. 2017;29(4):148–56.CrossRefPubMed
7.
go back to reference Cox L, Rovner ES. Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol. 2016;26(4):328–33.CrossRefPubMed Cox L, Rovner ES. Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol. 2016;26(4):328–33.CrossRefPubMed
8.
go back to reference Canda AE, Cross CR, Chapple CR. Pharmacology of the lower urinary tract and Management of Overactive Bladder. J Turkish-German Gynecol Assoc. 2006;7:146–57. Canda AE, Cross CR, Chapple CR. Pharmacology of the lower urinary tract and Management of Overactive Bladder. J Turkish-German Gynecol Assoc. 2006;7:146–57.
9.
go back to reference Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. American urological association; Society of Urodynamics, female pelvic medicine. J Urol. 2015;193(5):1572–80.CrossRefPubMed Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. American urological association; Society of Urodynamics, female pelvic medicine. J Urol. 2015;193(5):1572–80.CrossRefPubMed
10.
go back to reference Yi JH, Shin HJ, Kim SM, Han SW, Kim HJ, Oh MS. Does the exposure of urine samples to air affect diagnostic tests for urine acidification? Clin J Am Soc Nephrol. 2012;7(8):1211–6.CrossRefPubMedPubMedCentral Yi JH, Shin HJ, Kim SM, Han SW, Kim HJ, Oh MS. Does the exposure of urine samples to air affect diagnostic tests for urine acidification? Clin J Am Soc Nephrol. 2012;7(8):1211–6.CrossRefPubMedPubMedCentral
11.
go back to reference Demirbas A, Sarici H, Kilinc MF, Telli O, Ozgur BC, Doluoglu OG, et al. The relationship between acidic urinary pH and overactive bladder; alkalization of urine improves the symptoms of overactive bladder. Urol Int. 2015;95(2):223–6.CrossRefPubMed Demirbas A, Sarici H, Kilinc MF, Telli O, Ozgur BC, Doluoglu OG, et al. The relationship between acidic urinary pH and overactive bladder; alkalization of urine improves the symptoms of overactive bladder. Urol Int. 2015;95(2):223–6.CrossRefPubMed
12.
go back to reference Fjellstedt E, Denneberg T, Jeppsson JO, Tiselius HG. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol Res. 2001;29:295–302.CrossRefPubMed Fjellstedt E, Denneberg T, Jeppsson JO, Tiselius HG. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol Res. 2001;29:295–302.CrossRefPubMed
13.
go back to reference Kobayashi H, Yoshiyama M, Zakoji H, Takeda M, Araki I. Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int. 2009;104:1746–51.CrossRefPubMed Kobayashi H, Yoshiyama M, Zakoji H, Takeda M, Araki I. Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int. 2009;104:1746–51.CrossRefPubMed
14.
go back to reference Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev. 2009;60(1):267–77.CrossRefPubMed Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev. 2009;60(1):267–77.CrossRefPubMed
15.
go back to reference Sánchez-Freire V, Blanchard MG, Burkhard FC, Kessler TM, Kellenberger S, Monastyrskaya K. Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome. J Urol. 2011;186(4):1509–16.CrossRefPubMed Sánchez-Freire V, Blanchard MG, Burkhard FC, Kessler TM, Kellenberger S, Monastyrskaya K. Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome. J Urol. 2011;186(4):1509–16.CrossRefPubMed
16.
go back to reference Munday PE. Cymalon in the management of urinary tract symptoms. Genitourin Med. 1990;66(6):460–2. Munday PE. Cymalon in the management of urinary tract symptoms. Genitourin Med. 1990;66(6):460–2.
17.
18.
go back to reference Hohlbrugger G, Lentsch P. Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol. 1985;11(2):127–30.CrossRefPubMed Hohlbrugger G, Lentsch P. Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol. 1985;11(2):127–30.CrossRefPubMed
19.
go back to reference Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109(11):1584–91.CrossRefPubMed Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109(11):1584–91.CrossRefPubMed
20.
go back to reference Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol. 2004;42(1):1–26.CrossRefPubMed Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol. 2004;42(1):1–26.CrossRefPubMed
21.
go back to reference Cohen B, Laish I, Brosh-Nissimov T, Hoffman A, Katz LH, Braunstein R, et al. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial. Am J Emerg Med. 2013;31(12):1703–6.CrossRefPubMed Cohen B, Laish I, Brosh-Nissimov T, Hoffman A, Katz LH, Braunstein R, et al. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial. Am J Emerg Med. 2013;31(12):1703–6.CrossRefPubMed
22.
go back to reference Takahashi S, Takei M, Nishizawa O, Yamaguchi O, Kato K, Gotoh M, et al. Clin Guid Female Lower Urinary Tract Symp. 2016;8(1):5–29.CrossRef Takahashi S, Takei M, Nishizawa O, Yamaguchi O, Kato K, Gotoh M, et al. Clin Guid Female Lower Urinary Tract Symp. 2016;8(1):5–29.CrossRef
23.
go back to reference Wagg A, Compion G, Fahey A, Siddiqui E. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU Int. 2012 Dec;110(11):1767–74.CrossRefPubMed Wagg A, Compion G, Fahey A, Siddiqui E. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU Int. 2012 Dec;110(11):1767–74.CrossRefPubMed
24.
go back to reference Basra RK, Wagg A, Chapple C, Cardozo L, Castro-Diaz D, Pons ME, et al. A review of adherence to drug therapy in patients with overactive bladder. BJU Int. 2008;102(7):774–9.CrossRefPubMed Basra RK, Wagg A, Chapple C, Cardozo L, Castro-Diaz D, Pons ME, et al. A review of adherence to drug therapy in patients with overactive bladder. BJU Int. 2008;102(7):774–9.CrossRefPubMed
25.
go back to reference Yoshimura N. Underlying mechanisms of interstitial cystitis/painful bladder syndrome (IC/PBS). Nishinihon J Urol. 2009;71(6):243–52. Yoshimura N. Underlying mechanisms of interstitial cystitis/painful bladder syndrome (IC/PBS). Nishinihon J Urol. 2009;71(6):243–52.
26.
go back to reference Ueda T, Yoshida T, Tanoue H, Ito M, Tamaki M, Ito Y, et al. Urine alkalization improves the problems of pain and sleep in hypersensitive bladder syndrome. Int J Urol. 2014;21(5):512–7.CrossRefPubMed Ueda T, Yoshida T, Tanoue H, Ito M, Tamaki M, Ito Y, et al. Urine alkalization improves the problems of pain and sleep in hypersensitive bladder syndrome. Int J Urol. 2014;21(5):512–7.CrossRefPubMed
27.
go back to reference Tolouian R, Wild D, Lashkari MH, Najafi I. Oral alkalinizing solution as a potential prophylaxis against myoglobinuric acute renal failure: preliminary data from healthy volunteers. Nephrol Dial Transplant. 2005;20(6):1228–31.CrossRefPubMed Tolouian R, Wild D, Lashkari MH, Najafi I. Oral alkalinizing solution as a potential prophylaxis against myoglobinuric acute renal failure: preliminary data from healthy volunteers. Nephrol Dial Transplant. 2005;20(6):1228–31.CrossRefPubMed
Metadata
Title
Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study
Authors
Mehmet Giray Sönmez
Yunus Emre Göğer
Gökhan Ecer
Ahmet Atıcı
Mehmet Serkan Özkent
Ahmet Öztürk
Publication date
01-07-2018
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 7/2018
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3492-3

Other articles of this Issue 7/2018

International Urogynecology Journal 7/2018 Go to the issue